Cargando…
IGF2BP2 maybe a novel prognostic biomarker in oral squamous cell carcinoma
Aim: The main of the present study was to investigate the role of insulin-like growth factor 2 mRNA-binding protein 2 (IGF2BP2) in oral squamous cell carcinoma (OSCC) with the overarching of providing new biomarkers or potential therapeutic targets for OSCC. Methods: We combined datasets downloaded...
Autores principales: | Wang, Xiangpu, Xu, Haoyue, Zhou, Zuo, Guo, Siyuan, Chen, Renji |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Portland Press Ltd.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8859425/ https://www.ncbi.nlm.nih.gov/pubmed/35129592 http://dx.doi.org/10.1042/BSR20212119 |
Ejemplares similares
-
IGF2BP2 serves as a core m6A regulator in head and neck squamous cell carcinoma
por: Hu, Yuan, et al.
Publicado: (2022) -
CKS2 and RMI2 are two prognostic biomarkers of lung adenocarcinoma
por: Xiao, Dayong, et al.
Publicado: (2020) -
Identification of SPRR3 as a novel diagnostic/prognostic biomarker for oral squamous cell carcinoma via RNA sequencing and bioinformatic analyses
por: Yu, Lu, et al.
Publicado: (2020) -
Salivary LDOC1 is a gender-difference biomarker of oral squamous cell carcinoma
por: Liu, Chung-Ji, et al.
Publicado: (2019) -
Hsa_circ_0026134 expression promoted TRIM25- and IGF2BP3-mediated hepatocellular carcinoma cell proliferation and invasion via sponging miR-127-5p
por: Zhang, Wei, et al.
Publicado: (2020)